Iodine-125 is preferred for this purpose, due to better radiation penetration and shorter half-life (13 hours). I-125 is useful for Glomerular filtration rate (GFR) testing in the diagnosis or monitoring of patients with kidney disease. I-125 is used in Iodine-125 is used "therapeutically" in brachytherapy treatments of tumors. For radiotherapy ablation of tissues that absorb iodine (such as the thyroid), or that absorb an iodine-containing radiopharmaceutical, the beta-emitter iodine-131 is the preferred isotope. I is created by the electron capture decay of Xe, which is a synthetic isotope of xenon, itself created by neutron capture of the slightly radioactive Xe, which
Tincture of iodine Tincture of iodine Tincture of iodine, iodine tincture, or weak iodine solution is an antiseptic. It is usually 2–7% elemental iodine, along with potassium iodide or sodium iodide, dissolved in a mixture of ethanol and water. Tincture solutions are characterized by the presence of alcohol. It was used from 1908 in pre-operative skin preparation by surgeon Antonio Grossich. In the United Kingdom the development of an iodine solution for skin sterilisation was pioneered by Lionel Stretton. The "British Medical Journal" published the detail of his work at Kidderminster Infirmary in 1909. Stretton used a much weaker solution than that used